Neptune Biotech: Announcement on the extension of the company\'s controlling shareholder\'s commitment to avoid competition in the same industry
Neptune Biotech: Announcement of Independent Directors on Public Call for Voting Rights
Haiwang Biotech: Audit Opinions of the Supervisory Board on Matters Related to the 17th Meeting of the 9th Board of Supervisors
Haiwang Biotech: Announcement on Additional Provisional Proposals for the 2024 Fourth Extraordinary General Meeting of Shareholders and Supplementary Notice to the Shareholders\' Meeting
Neptune Biotech: Announcement of Resolutions of the 21st Meeting of the 9th Board of Directors
Haiwang Biotech: Announcement of Resolutions of the 17th Meeting of the 9th Board of Supervisors
Neptune Biotech: Announcement on changing partners for the annual audit project
Haiwang Biotech: Announcement on the Notice of Convening the Fourth Extraordinary General Meeting of Shareholders in 2024
Neptune Biotech: Announcement on cumulative lawsuits and arbitration
Haiwang Biotech: Announcement of Resolutions of the 20th Meeting of the 9th Board of Directors
Neptune Biotech: Investor Relations Activity Record Form for December 12, 2024
Haiwang Biotech: Announcement on Release and Pledge of Some Shareholders\' Shares
Neptune Biotech: Announcement on the progress of external guarantees and the cancellation of external guarantees
Neptune Biotech: Announcement on progress in providing financial support
Neptune Biotech: Announcement on the implementation of guarantees for holding subsidiaries
Haiwang Biotech: Announcement on participating in the 2024 Group Reception Day for Listed Companies in Shenzhen
Neptune Biotech: Announcement of Resolutions of the 19th Meeting of the 9th Board of Directors
Haiwang Biotech: Announcement of Resolutions of the 16th Meeting of the 9th Board of Supervisors
Neptune Biotech: Announcement on completing the registration of industrial and commercial changes
Haiwang Biotech: Rectification Report on the Decision of the Shenzhen Regulatory Bureau of the China Securities Regulatory Commission to Order Corrective Measures against the Company